Unlock instant, AI-driven research and patent intelligence for your innovation.

akr1c3 inhibitor or pharmaceutically acceptable salt thereof, preparation method and use thereof

A technology of inhibitor and application, applied in the field of aldehyde and ketone reductase and its preparation

Active Publication Date: 2020-09-08
南京芩领医药科技有限公司
View PDF2 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

At present, there are few research reports on AKR1C3 biological function research and inhibitors in China. The development of inhibitors specifically targeting AKR1C3 may provide an effective treatment strategy for tumor treatment. At the same time, AKR1C3 inhibitors can be used as tool molecules for pathological mechanism research. Most importantly, the discovery of effective drugs targeting AKR1C3 may provide a new research direction for reversing drug resistance and overcome key problems in tumor treatment

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • akr1c3 inhibitor or pharmaceutically acceptable salt thereof, preparation method and use thereof
  • akr1c3 inhibitor or pharmaceutically acceptable salt thereof, preparation method and use thereof
  • akr1c3 inhibitor or pharmaceutically acceptable salt thereof, preparation method and use thereof

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0033] (1) Synthesis of diethyl 2-(3-fluoro-4-nitrophenyl)-2-methylmalonate (intermediate 2a)

[0034] 2,4-Difluoronitrobenzene 1a (2.2ml, 20mmol) was dissolved in DMF solution, NaOH solid (800mg, 20mmol) was added, and diethyl methylmalonate (3.68ml, 21.6 mmol), stirred overnight at room temperature. After the reaction was completed, 120ml of water was added, extracted three times with DCM, washed three times with brine, combined the organic layers, and dried over anhydrous sodium sulfate. Spin dry, and separate by column chromatography (eluent: PE / EA=20 / 1, v / v). A pale yellow oily liquid was obtained with a yield of 87%. 1 H NMR (300MHz, DMSO-d 6 ): δ8.17(t, J=8.4Hz, 1H), 7.61(dd, J=13.0, 2.0Hz, 1H), 7.45-7.36(m, 1H), 4.22(q, J=7.1Hz, 4H) , 1.82(s, 3H), 1.19(t, J=7.1Hz, 6H).

[0035] (2) Synthesis of diethyl 2-(4-amino-3-fluorophenyl)-2-methylmalonate (intermediate 3a)

[0036] To a solution of intermediate 2a (3.23 g, 10.3 mmol) in ethanol (100 mL) was added 10% Pd / C ...

Embodiment 2

[0042] Synthesis of 2-(2-fluoro-3'-(trifluoromethyl)-[1,1'-biphenyl]-4-yl)propionic acid

[0043] Referring to the synthesis method of Example 1, the raw material was replaced with 3-trifluoromethylphenylboronic acid, separated by column chromatography (eluent: PE / EA=20 / 1, v / v) to obtain a yellow solid, which was detected by TLC as One point, there is fluorescence under the ultraviolet lamp at 254nm, but no fluorescence at 365nm, the yield is 59%, m.p.50-52°C. 1 H NMR (500MHz, CDCl 3 ): δ7.80(s, 1H), 7.74(d, J=7.6Hz, 1H), 7.65(d, J=7.7Hz, 1H), 7.58(t, J=7.7Hz, 1H), 7.43(t , J=8.0Hz, 1H), 7.31-7.16(m, 2H), 3.83(q, J=7.1Hz, 1H), 1.59(d, J=7.2Hz, 3H). 13 C NMR (125MHz, DMSO-d 6 ): δ175.23, 160.30, 158.34, 144.53, 136.34, 133.27, 131.23, 130.13, 129.80, 125.57, 124.90, 124.68, 123.47, 115.8, 115.63, 44.63, 18.68. MS (ESI) for m 16 h 12 f 4 o 2 [M-H] - 311.0807; found 311.0715. HPLC (75% methanolin water with 0.1% HCOOH): t R =12.17min, 98.91%.

Embodiment 3

[0045] Synthesis of 2-(2-fluoro-3'-hydroxy-[1,1'-biphenyl]-4-yl)propionic acid

[0046] Referring to the synthesis method of Example 1, the raw material was replaced with 3-hydroxyphenylboronic acid, and when the acid was adjusted (pH=2) during hydrolysis and decarboxylation post-treatment, a white solid was precipitated, and a white solid was obtained after suction filtration, which was detected by TLC as one point, and the ultraviolet There is fluorescence at 254nm and no fluorescence at 365nm. The yield is 54%, m.p.153-155°C. 1 H NMR (300MHz, DMSO-d 6 ): δ12.70(s, 1H), 9.57(s, 1H), 7.46(dt, J=16.7, 8.5Hz, 1H), 7.35-7.15(m, 3H), 7.03-6.89(m, 2H), 6.86-6.73(m, 1H), 3.77(q, J=7.1Hz, 1H), 1.41(d, J=7.1Hz, 3H). 13 C NMR (125MHz, DMSO-d 6 ):δ175.35,160.27,158.32,157.86,143.43,143.37,136.56,130.99,130.96,130.05,127.24,127.14,124.41,124.38,119.87,119.85,116.05,116.03,115.69,115.50,115.24,44.57,18.72. MS(ESI)m / z calcd for C 15 h 13 FO 3 [M-H] -259.0849; found 259.0784. HPLC ...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

Disclosed are an AKR1C3 inhibitor or a pharmaceutically acceptable salt of same, a preparation method for same, and uses thereof. A structural optimization is performed with a nonsteroidal anti-inflammatory medicament, flurbiprofen, serving as a lead compound. Disclosed are the biphenyl AKR1C3 inhibitor as represented by formula (I) and the preparation method therefor. As proven in target activity tests, the compound of the present invention is provided with an activity for significantly inhibiting AKR1C3, can be further developed into a medicament for treating or preventing diseases by inhibiting aldehyde ketone reductase AKR1C3, and lays a molecular foundation for studies on mechanisms related to tumor resistance.

Description

technical field [0001] The invention relates to aldehyde and ketone reductase and its preparation method and application, in particular to an AKR1C3 inhibitor. Background technique [0002] Aldo-ketone reductases (Aldo-keto reductases, AKR) is a protein superfamily, which has been divided into 15 families, and the molecular weight of members is 36-40kDa. Most AKR members can catalyze redox reactions in vivo, and their substrates range widely, including sugars, fatty aldehydes, bile acids, steroid hormones, prostaglandins, and carcinogens. There are four human subtypes in the first family C subfamily (AKR1C) of the aldoketone reductase family, namely AKR1C1, AKR1C2, AKR1C3 and AKR1C4. These four proteins are expressed and distributed in different tissues and involve various biochemical functions. AKR1C3, also known as peripheral type 5 17β-hydroxysteroid dehydrogenase (17β-hydroxysteroid dehydrogenase, 17β-HSD), can convert androgen 4-androstene-3,17-dione (4-Androstene-3,17...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Patents(China)
IPC IPC(8): C07C59/64C07C59/52C07C57/58C07C63/72C07C51/353C07C51/363C07C51/367C07C323/62C07C319/20C07C205/56C07C201/12C07C253/30C07C255/57C07D213/55C07D215/12C07D215/14A61P35/00A61K31/47A61K31/4406A61K31/4409A61K31/277A61K31/192
CPCA61P35/00C07C57/58C07C59/52C07C59/64C07C63/72C07C205/56C07C255/57C07C323/62C07D213/55C07D215/12C07D215/14C07C2601/02
Inventor 孙昊鹏何思雨刘阳
Owner 南京芩领医药科技有限公司